Mindfulness-Oriented Recovery Enhancement (MORE) in Heroin Addiction | MicrobiomeTrials← Back to trialsNCT04112186
Mindfulness-Oriented Recovery Enhancement (MORE) in Heroin Addiction
CompletedNAINTERVENTIONAL
Trial Details
Start: 2020-06-21Est. Completion: 2024-09-11
Enrollment target: 157 participants Locations- Icahn School of Medicine at Mount Sinai, New York, New York, United States
Other microbiome trials you might be interested in
Opioid Use Disorder
The opioid overdose epidemic has persisted for several decades and is now further complicated by the permeation of fenta…
Baltimore, United StatesEst. completion Jan 1, 2030
Opiate-Related DisordersOpiate Substitution Treatment
The goal of this clinical trial is to learn if/how an AI chatbot can support patients who in recovery for substance use,…
Boston, United StatesCompleted Jun 1, 2026
Phase 2
Recruiting
It is a double blind controlled study to test the hypothesis that it's possible to predict the response to naltrexone in…
São Paulo, BrazilEst. completion Dec 2026